SVP, Global Sales & Video Svcs of Neoleukin Therapeutics, Inc. (NASDAQ:NLTX), Walkey Carl, sells 2,400 shares worth $31,752

According to Neoleukin Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 05 04:51 PM, company SVP, Global Sales & Video Svcs, Walkey Carl disclosed selling 2,400 shares at a cost of $13.23. At the time of this transaction (Feb 03), this trade was worth $31,752 in total. As of Feb 03, Walkey Carl now owns 1,383,562 shares in total worth about $19,217,676.18.

For the last few recent trades made by Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) SVP, Global Sales & Video Svcs, Walkey Carl, we have the following information:

    Posted by on Friday February 05 2021, 5:25 PM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0

    Comments are closed

    Featured Press Releases

    Log in